COMMUNIQUÉS West-GlobeNewswire

Professional Hockey Players’ Association Chooses Brain Armor® as Official Brain Health Supplement
27/03/2019
Brookfield, WI, March 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Trident Brands Inc. (OTCQB: TDNT), a biotech and nutraceutical company, through their Brain Armor® subsidiary, is pleased to announce that the [...]
Resolution passed at the Annual General Meeting
27/03/2019
Orphazyme A/S Company announcement No. 10/2019 Company Registration No. 32266355 Copenhagen, March 27, 2019 – Orphazyme A/S (ticker: ORPHA.CO), a biopharmaceutical company dedicated to developing treatments for patients [...]
New Psychemedics Offering Further Enhances Cocaine Detection
27/03/2019
Industry’s first commercial application of hydroxycocaines for detection SAN ANTONIO, TX and ACTON, MA, March 27, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD ), the world leader in detecting drugs of [...]
Genfit: MISE À DISPOSITION DU PROSPECTUS AYANT RECU LE VISA NO. 19-118 DE L’AUTORITÉ DES MARCHÉS FINANCIERS EN DATE DU 27 MARS 2019 DANS LE CADRE DE SON INTRODUCTION EN BOURSE AUX ÉTATS-UNIS
27/03/2019
CE COMMUNIQUÉ N’EST PAS DESTINÉ A ÊTRE PUBLIÉ, DISTRIBUÉ OU DIFFUSÉ, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS D’AMÉRIQUE NI À DES RESSORTISSANTS AMÉRICAINS (« U.S. PERSONS »), POUR LEUR BÉNÉFICE OU POUR LEUR COMPTE [...]
Announcement from Nordic Transport Group A/S regarding consolidation with NeuroSearch and notification from Nasdaq to NeuroSearch
27/03/2019
Company announcement 27 March 2019 NeuroSearch A/S ("NeuroSearch") has today received the attached announcement from Nordic Transport Group ("NTG)". Proposals will be made to the Annual General Meeting of NeuroSearch to [...]
Harvest One Executing on Brands and Distribution Strategy -- CFN Media
27/03/2019
SEATTLE, March 27, 2019 (GLOBE NEWSWIRE) -- NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Resverlogix Announces Ninth Positive Data Safety Monitoring Board Recommendation for Phase 3 Study of Apabetalone
27/03/2019
BETonMACE trial to continue as planned without modification CALGARY, Alberta, March 27, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX:RVX) today announces the independent Data and [...]
ViroGates publishes its Annual Report 2018
27/03/2019
Company announcement no. 3-2018 Birkerød, 27 March 2019 ViroGates A/S (Nasdaq First North Denmark: VIRO), who delivers blood test systems, primarily for emergency departments in hospitals, today published its Annual [...]
Immutep to Host Eftilagimod Alpha Clinical Development Update Global Webcast
27/03/2019
SYDNEY, Australia, March 27, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune [...]
Thrive Behavioral Sciences Appoints Dr. Faizi Ahmed its Medical Director for Tampa
27/03/2019
Tampa, FL, March 27, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Thrive Behavioral Sciences, a leading provider of behavioral health services to skilled nursing and assisted living facilities, announced today the [...]
The Announcement On Cancellation Of The Extraordinary Shareholders' Meeting Оf JSC Olainfarm
27/03/2019
On January 9, 2019, the Board of JSC Olainfarm, announced the convocation of the extraordinary shareholders' meeting on April 1st, 2019, based on the request received on the 4th of January from the persons who indicated [...]
Genfit: GENFIT ANNOUNCES TRADING RESUMPTION OF ITS SHARES AND OF ITS OCEANES ON EURONEXT PARIS AND EURONEXT ACCESS
27/03/2019
FOR IMMEDIATE RELEASE GENFIT ANNOUNCES TRADING RESUMPTION OF ITS SHARES AND OF ITS OCEANES ON EURONEXT PARIS AND EURONEXT ACCESS Lille (France), Cambridge (Massachusetts, United States), March 27, 2019 – 3:00 pm CET – [...]
Genfit : GENFIT ANNONCE LA REPRISE DU COURS DE SES ACTIONS ET DE SES OCEANES SUR EURONEXT PARIS ET EURONEXT ACCESS
27/03/2019
CE COMMUNIQUÉ N’EST PAS DESTINÉ A ÊTRE PUBLIÉ, DISTRIBUÉ OU DIFFUSÉ, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS D’AMÉRIQUE NI À DES RESSORTISSANTS AMÉRICAINS (« U.S. PERSONS »), POUR LEUR BÉNÉFICE OU POUR LEUR COMPTE [...]
Invitation to Orion's Capital Markets Day in Helsinki on Wednesday 22 May 2019
27/03/2019
ORION CORPORATION PRESS RELEASE 27 MARCH 2019 Invitation to Orion's Capital Markets Day in Helsinki on Wednesday 22 May 2019 Orion Corporation has the pleasure to invite analysts, institutional investors and media to [...]
Tizona Announces Initiation of Phase 1/1b Study with Novel Cancer Immunotherapy TTX-030 and First Public Presentation of Pre-Clinical Data with TTX-030 at AACR 2019
27/03/2019
TTX-030 is the first anti-CD39 therapeutic to be studied in patients SOUTH SAN FRANCISCO, Calif., March 27, 2019 (GLOBE NEWSWIRE) -- Tizona Therapeutics, Inc., a privately held immunotherapy company, today announced [...]
Rhinogram Telehealth Capabilities Now Integrated Into SelectBraces Platform
27/03/2019
Integration allows for secure communication exchange, high quality patient experience between orthodontist practices and prospective patients CHATTANOOGA, Tenn., March 27, 2019 (GLOBE NEWSWIRE) -- Rhinogram , a leader [...]
Eloxx Pharmaceuticals Presents Positive New Data for Lead Investigational Drug, ELX-02, at the European Cystic Fibrosis Society (ECFS) Basic Science Conference
27/03/2019
ELX-02 shows significant increases in CFTR protein expression and localization correlating with functional activity in Cystic Fibrosis patient-derived organoids bearing CFTR nonsense mutations In previous studies, the [...]
AdventHealth is the first in Florida to use state-of-the-art robotic technology for spinal procedures
27/03/2019
Medtronic’s Mazor X Stealth Edition technology improves accuracy during minimally invasive surgery ORLANDO, Fla., March 27, 2019 (GLOBE NEWSWIRE) -- AdventHealth Altamonte Springs is the first in the state to use a [...]
Brainsway Reports Financial Results for Fourth Quarter and Full-Year 2018
27/03/2019
Full-Year 2018 revenues of $16.4 million increased 47% over full-year 2017 Fourth quarter revenues of $4.8 million, up 32% over the prior year quarter HACKENSACK, N.J., March 27, 2019 (GLOBE NEWSWIRE) -- Brainsway Ltd [...]

Pages